Cite
MLA Citation
E. Jacobsen et al.. “CHARACTERIZATION OF DUVELISIB IN PATIENTS WITH REFRACTORY MARGINAL ZONE LYMPHOMA: DATA FROM THE PHASE 2 DYNAMO TRIAL.” Hematological oncology, vol. 37, n.d., pp. 400–401. http://access.bl.uk/ark:/81055/vdc_100086192883.0x000045